Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|August 3, 2011
N-imidazolebenzyl-histidine substitution in somatostatin and in its octapeptide analogue modulates receptor selectivity and functionJudit Erchegyi, Renzo Cescato, Beatrice Waser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2010
Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analogJean Claude Reubi, Judit Erchegyi, Renzo Cescato, et al.
EJNMMI Research|January 5, 2012
Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancersDavid Chatenet, Renzo Cescato, Beatrice Waser, et al.
Biopolymers|July 26, 2008
Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMRChristy Rani R Grace, Judit Erchegyi, Jean Claude Reubi, et al.
Journal of Medicinal Chemistry|December 12, 2003
Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMRChristy Rani R Grace, Steven C Koerber, Judit Erchegyi, et al.
Journal of Medicinal Chemistry|July 21, 2006
Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMRChristy Rani R Grace, Judit Erchegyi, Steven C Koerber, et al.
Journal of Medicinal Chemistry|December 12, 2003
Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabelingJudit Erchegyi, Beatrice Waser, Jean-Claude Schaer, et al.
Journal of Medicinal Chemistry|January 22, 2005
Somatostatin receptor 1 selective analogues: 3. Dicyclic peptidesJean E Rivier, Dean A Kirby, Judit Erchegyi, et al.
Journal of Medicinal Chemistry|January 22, 2005
Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMRChristy Rani R Grace, Lukas Durrer, Steven C Koerber, et al.
Pageof 3